Ainos, Inc. (AIMD)

1.0400 -0.0100 (-0.95%) At close: 04:00PM EDT

Ainos, Inc.

8880 Rio San Diego Drive
Suite 800
San Diego, CA 92108
United States
858 869 2986
https://www.ainos.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 46

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Chun-Hsien Tsai	Chairman of Board, President & CEO	112.12k	N/A	1970
Mr. Lawrence Kennedy Lin	Executive Vice President of Operations	144k	N/A	1969
Mr. Hsin-Liang Lee	Chief Financial Officer	N/A	N/A	1971
Mr. Chih-Heng Lu	Director of Corporate Developoment	N/A	N/A	1980

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Corporate governance

Ainos, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.